|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2003-12-15
|
|
pubmed:abstractText |
To evaluate response rate, response duration, overall survival (OS), and toxicity in primary CNS lymphoma (PCNSL) after systemic and intraventricular chemotherapy with deferred radiotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AtasoyAslihanA,
pubmed-author:BodeUdoU,
pubmed-author:DeckertMartinaM,
pubmed-author:DiehlVolkerV,
pubmed-author:EgererGerlindeG,
pubmed-author:EngertAndreasA,
pubmed-author:FimmersRolfR,
pubmed-author:GlasmacherAxelA,
pubmed-author:HelmstaedterChristophC,
pubmed-author:KlockgetherThomasT,
pubmed-author:KroschinskyFrankF,
pubmed-author:PelsHendrikH,
pubmed-author:ReichmannHeinzH,
pubmed-author:SchackertGabrieleG,
pubmed-author:SchallerCarloC,
pubmed-author:SchlegelUweU,
pubmed-author:Schmidt-WolfIngo G HIG,
pubmed-author:SchulzHolgerH,
pubmed-author:Vogt-SchadenMarliesM,
pubmed-author:ZellnerAntonA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4489-95
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14597744-Adult,
pubmed-meshheading:14597744-Aged,
pubmed-meshheading:14597744-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14597744-Central Nervous System Neoplasms,
pubmed-meshheading:14597744-Cyclophosphamide,
pubmed-meshheading:14597744-Cytarabine,
pubmed-meshheading:14597744-Dexamethasone,
pubmed-meshheading:14597744-Female,
pubmed-meshheading:14597744-Humans,
pubmed-meshheading:14597744-Ifosfamide,
pubmed-meshheading:14597744-Lymphoma,
pubmed-meshheading:14597744-Male,
pubmed-meshheading:14597744-Methotrexate,
pubmed-meshheading:14597744-Middle Aged,
pubmed-meshheading:14597744-Pilot Projects,
pubmed-meshheading:14597744-Prednisolone,
pubmed-meshheading:14597744-Survival Analysis,
pubmed-meshheading:14597744-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
|
|
pubmed:affiliation |
Department of Neurology, University of Bonn, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
